
Articles
-
1 week ago |
trendlyne.com | Omkar Chitnis
By Omkar Chitnis The Gujarati phrase Bhav Bhagwan Che — Price is God — has echoed louder than ever in recent months. Since hitting a year-to-date low of 21,760 on April 7, the Nifty 50 has surged 14.2% and now hovers near the 25,000 mark. Riding this rally, promoters have wasted no time offloading stakes through a flurry of bulk and block deals. Generally, high promoter and institutional shareholding signals investor confidence in a company.
-
1 week ago |
trendlyne.com | Omkar Chitnis
By Omkar Chitnis Motilal Oswal reiterates its ‘Buy’ rating on this tea & coffee company with a target price of Rs 1,360, a 26.9% upside. Analysts Sumant Kumar, Meet Jain, and others highlight the company’s focus on growing its new businesses while maintaining core operations strength. Tata Consumer’s market share rose by 30 bps in FY25, helped by growth in the salt business. Its tea segment now holds a 20% market share, boosted by new product launches and strategic pricing.
-
1 week ago |
trendlyne.com | Omkar Chitnis
By Omkar Chitnis When foreign Institutional Investors (FIIs) buy or reduce stakes, the ground moves under India’s stock market. Their large-figure decisions often trigger sharp stock reactions. In recent quarters, FII flows have been unpredictable as India’s union election, the US presidential race, geopolitical tensions, and tariff worries kept Indian equity markets volatile.
-
3 weeks ago |
trendlyne.com | Omkar Chitnis
By Omkar Chitnis In volatile markets, dividends offer something rare: predictability. For many investors, they’re a steady source of income amid the noise. While some chase gains from rising stock prices, other investors prefer the comfort of regular income through dividend paying stocks. Public Sector Undertakings (PSUs) have long been a favourite among investors for this steady return.
-
3 weeks ago |
trendlyne.com | Omkar Chitnis
By Omkar Chitnis Prabhudas Lilladhar maintains a ‘Buy’ rating on this hospitals player with a target price of Rs 1,950, a 11.3% upside. The company’s management confirmed its focus on expansion over the next 3–4 years. It aims to increase capacity and improve efficiency by adding more specialised, higher-value beds.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →